GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » OSE Immunotherapeutics SA (FRA:6OP) » Definitions » Net Issuance of Debt

OSE Immunotherapeutics (FRA:6OP) Net Issuance of Debt : €-3.34 Mil (TTM As of Dec. 2024)


View and export this data going back to 2015. Start your Free Trial

What is OSE Immunotherapeutics Net Issuance of Debt?

Net issuance of debt is the cash a company received or spent through debt related activities such as debt issuance or debt repayment. If a company pays down its debt during the period, this number will be negative. If a company issued more debt, it receives cash and this number is positive. OSE Immunotherapeutics's net issuance of debt for the six months ended in Dec. 2024 was €0.99 Mil. Its net issuance of debt for the trailing twelve months (TTM) ended in Dec. 2024 was €-3.34 Mil.

OSE Immunotherapeutics Net Issuance of Debt Historical Data

The historical data trend for OSE Immunotherapeutics's Net Issuance of Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

OSE Immunotherapeutics Net Issuance of Debt Chart

OSE Immunotherapeutics Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Net Issuance of Debt
Get a 7-Day Free Trial Premium Member Only Premium Member Only 6.64 15.24 11.05 2.30 -3.34

OSE Immunotherapeutics Semi-Annual Data
Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24
Net Issuance of Debt Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 11.19 1.00 1.31 -4.33 0.99

OSE Immunotherapeutics Net Issuance of Debt Calculation

This is the cash a company received or spent through debt related activities such as debt issuance or debt repayment. If a company pays down its debt during the period, this number will be negative. If a company issued more debt, it receives cash and this number is positive.

Net Issuance of Debt for the trailing twelve months (TTM) ended in Dec. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was €-3.34 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

OSE Immunotherapeutics Net Issuance of Debt Related Terms

Thank you for viewing the detailed overview of OSE Immunotherapeutics's Net Issuance of Debt provided by GuruFocus.com. Please click on the following links to see related term pages.

OSE Immunotherapeutics Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » OSE Immunotherapeutics SA (FRA:6OP) » Definitions » Net Issuance of Debt
Comparable Companies
XPAR:ALCLS XPAR:NANO XPAR:ALSEN XPAR:IPH XPAR:TNG XPAR:MAAT XPAR:GNFT XPAR:DBV XPAR:ADOC XPAR:ALGAE VRTX ASX:CSL REGN XKRX:207940 ALNY XBRU:ARGX XBRU:UCB ONC XKRX:068270 BNTX
Traded in Other Exchanges
0RAD:UK OSE:France
Address
22, Boulevard Benoni Goullin, Nantes, FRA, 44200
Website
http://www.ose-immuno.com
OSE Immunotherapeutics SA is a France-based biotechnology company focused on the development of immunotherapies for immune activation and regulation in the fields of immuno-oncology and autoimmune diseases. The product portfolio of the company comprises Tedopi, OSE-172, OSE-703, FR104 and OSE-127.

OSE Immunotherapeutics Headlines

No Headlines